Literature DB >> 615489

The effect of unrecognized drug abuse on diagnosis and therapeutic outcome.

R C Hall, M K Popkin, R Devaul, S K Stickney.   

Abstract

One-hundred and ninety-five consecutive psychiatric outpatients had urine sampled for the presence of opiates, cocaine, barbiturates, and amphetamines. All patients had demographic variables, diagnostic information, and treatment course analyzed in a blind fashion using preselected criteria. Patterns of abuse were defined for the 13.3% of the total sample who were covert abusers. An analysis of diagnostic accuracy for abusing and nonabusing populations indicated that covert abuse markedly distorted diagnosis and management. The study indicates that demographic variables and previous history were not reliable predicators of covert abuse. Drug abuse was a major factor in distorting the accuracy of diagnosis. Drug abusers were significantly less likely to improve with therapy than were nonabusers. Barbiturate abusers were most likely to suffer from adverse drug reactions. Urine screening for drugs was the single most valuable diagnostic tool and was felt to be indicated in all cases where diagnostic confusion was present. Therapists saw the covert abuser as sick out of proportion to their social behavior, were perplexed and frightened by these patients' dependency, and perceived them as too brittle for therapy. Therapists behaved very differently with these patients than with diagnostically matched controls. They misdiagnosed them four times more often, missed appointments with them seven times more often, and were ten times more likely to refer them to another therapist or agency. Therapist anxiety and "flight from therapy" with covertly abusing patients are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 615489     DOI: 10.3109/00952997709007003

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  7 in total

1.  Treatment of the mentally ill chemical abuser: description of the Hutchings Day Treatment Program.

Authors:  K B Carey
Journal:  Psychiatr Q       Date:  1989

2.  Using information technology to evaluate the detection of co-occurring substance use disorders amongst patients in a state mental health system: implications for co-occurring disorder state initiatives.

Authors:  Frederick Y Huang; Douglas M Ziedonis; Hsou Mei Hu; Anna Kline
Journal:  Community Ment Health J       Date:  2007-08-10

3.  Substance use reduction in the context of outpatient psychiatric treatment: a collaborative, motivational, harm reduction approach.

Authors:  K B Carey
Journal:  Community Ment Health J       Date:  1996-06

Review 4.  Drug abuse, psychiatric disorders, and AIDS. Dual and triple diagnosis.

Authors:  S L Batki
Journal:  West J Med       Date:  1990-05

5.  Meta-analysis of self-reported substance use compared with laboratory substance assay in general adult mental health settings.

Authors:  Matthew M Large; Glen Smith; Grant Sara; Michael B Paton; Karina Karolina Kedzior; Olav B Nielssen
Journal:  Int J Methods Psychiatr Res       Date:  2012-02-27       Impact factor: 4.035

Review 6.  The treatment of persons with dual diagnoses in a rural community.

Authors:  R H Howland
Journal:  Psychiatr Q       Date:  1995

Review 7.  Detection of substance use disorders in severely mentally ill patients.

Authors:  R E Drake; A I Alterman; S R Rosenberg
Journal:  Community Ment Health J       Date:  1993-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.